Demo Marketing Trials 
H1 Blog
DECEMBER 18, 2023
How will AI impact clinical trials? DOLs will also increasingly turn back to in-person interactions, conferences, public speaking, and other direct means to voice their opinions and establish a more credible presence, moving away from digital platforms.” – Alexandra Moens, Senior Director of Product Marketing 4.
H1 Blog
JUNE 7, 2023
Clinical trial success is a key factor for pharma companies when designing and recruiting patients into trials. This data can also provide guidance in terms of diversifying clinical trials to include different types of population demographics such as age, gender, race, ethnicity, or geographic location.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
H1 Blog
SEPTEMBER 26, 2023
Breaking Down Barriers to International Clinical Trials Global Disruptions, Health Equity & Data Sharing As the U.S. When time is of the essence, like in a global pandemic, how do you scale trials internationally for success? Additionally, clinical trials are no longer confined to one country or region.
H1 Blog
OCTOBER 16, 2023
AI can help in speeding up various phases like target identification, molecule optimization, and pre-clinical testing, thereby reducing the cost and time to bring a drug to market. Faster Time-to-Market: AI-driven predictive maintenance can reduce machine downtime, ensuring smoother manufacturing processes and quicker product delivery.
H1 Blog
JULY 30, 2024
Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. This allows the trial to achieve more precise results at the indication level through leveraging comprehensive information from across the globe. “I
H1 Blog
JULY 5, 2023
The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market.
H1 Blog
JUNE 8, 2023
The drug development process is known to be often expensive, lengthy, and full of trial and error before finding success. This not only ensures overall safety but also creates opportunities for better access equity throughout different regions and markets worldwide.
Expert insights. Personalized for you.
64 
Let's personalize your content